Pharma Foods International Co., Ltd. (TYO:2929)
Japan · Delayed Price · Currency is JPY 556.00
+2.00 (0.36%)
Aug 4, 2026, 12:32 PM JST
TYO:2929 Ratios and Metrics
Market cap in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| 16,090 | 25,612 | 30,908 | 48,344 | 42,491 | 84,180 | |
Market Cap Growth | -37.39% | -17.14% | -36.07% | 13.78% | -49.52% | 190.14% |
Enterprise Value | 24,536 | 28,535 | 33,591 | 54,775 | 47,604 | 81,673 |
Last Close Price | 554.00 | 852.21 | 1029.62 | 1531.64 | 1318.40 | 2573.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
PE Ratio | 37.29 | 69.60 | 9.64 | 15.69 | - | 21.92 |
PS Ratio | 0.24 | 0.39 | 0.50 | 0.71 | 0.71 | 1.80 |
PB Ratio | 1.60 | 2.22 | 2.67 | 5.02 | 6.01 | 9.95 |
P/TBV Ratio | 1.61 | 2.24 | 2.71 | 5.15 | 6.28 | 10.17 |
P/FCF Ratio | - | - | 6.65 | 8.42 | - | 14.55 |
P/OCF Ratio | - | - | 5.63 | 7.89 | - | 14.18 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
EV/Sales Ratio | 0.37 | 0.44 | 0.54 | 0.80 | 0.79 | 1.75 |
EV/EBITDA Ratio | 13.02 | 9.05 | 5.58 | 13.18 | 29.75 | 13.95 |
EV/EBIT Ratio | 21.64 | 12.05 | 6.57 | 15.17 | 44.08 | 14.39 |
EV/FCF Ratio | - | - | 7.23 | 9.54 | - | 14.12 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Debt / Equity Ratio | 1.71 | 1.09 | 1.46 | 2.09 | 2.38 | 0.58 |
Debt / EBITDA Ratio | - | 4.00 | 2.81 | 4.84 | 10.54 | 0.84 |
Debt / FCF Ratio | - | - | 3.64 | 3.50 | - | 0.85 |
Net Debt / Equity Ratio | 0.84 | 0.30 | 0.11 | 0.39 | 1.13 | -0.58 |
Net Debt / EBITDA Ratio | 4.43 | 1.10 | 0.20 | 0.91 | 5.01 | -0.84 |
Net Debt / FCF Ratio | -1.86 | -1.75 | 0.26 | 0.66 | -1.23 | -0.85 |
Asset Turnover | 1.99 | 1.89 | 1.71 | 2.04 | 2.31 | 3.01 |
Inventory Turnover | 1.60 | 1.74 | 2.10 | 2.19 | 2.74 | 3.18 |
Quick Ratio | 0.55 | 0.72 | 0.86 | 0.86 | 0.71 | 1.34 |
Current Ratio | 1.04 | 1.19 | 1.18 | 1.13 | 1.03 | 1.63 |
Return on Equity (ROE) | 4.23% | 3.18% | 30.21% | 36.89% | -4.81% | 57.45% |
Return on Assets (ROA) | 2.14% | 4.28% | 8.78% | 6.70% | 2.59% | 22.85% |
Return on Invested Capital (ROIC) | 6.51% | 2.57% | 24.83% | 22.03% | -3.04% | 86.22% |
Return on Capital Employed (ROCE) | 10.70% | 18.70% | 38.10% | 30.40% | 12.90% | 56.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Earnings Yield | 2.67% | 1.44% | 10.37% | 6.37% | -0.88% | 4.56% |
FCF Yield | -28.20% | -7.74% | 15.03% | 11.87% | -15.37% | 6.87% |
Dividend Yield | 4.48% | 2.93% | 2.43% | 1.44% | 1.52% | 0.78% |
Payout Ratio | - | 213.04% | 19.53% | 18.76% | - | 7.55% |
Buyback Yield / Dilution | 0.05% | -1.06% | 1.51% | 0.47% | 0.18% | -0.04% |
Total Shareholder Return | 4.53% | 1.87% | 3.94% | 1.91% | 1.70% | 0.73% |